FINEPOINT CAPITAL LP

Adviser information for FINEPOINT CAPITAL LP last updated from Form ADV on March 21st, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Partnership
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 20
Investment Advisory/Research 12
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 2 $4.0B
Non-Discretionary 0 $0
Total 2 $4.0B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 2 $4.0B
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 0

Services

Advisory Services Portfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-79330
SEC ERA File Number 801-79330
SEC CIK Numbers 1608126
SEC CRD Numbers 170668
Legal Entity Identifier 54930083XNETY8RL8H89

Principal Office

500 BOYLSTON STREET, 24TH FLOOR
BOSTON
MA
United States
Monday - Friday, 8:00 AM - 5:00 PM
Tel: 617-336-2200, Fax: 617-336-2276

Chief Compliance Officer

STACY VEZINA
GENERAL COUNSEL
500 BOYLSTON STREET, 24TH FLOOR
BOSTON
MA
United States
Tel: 617-336-2212
Fax: 617-336-2276
(Full email address available in API data)

Industry Affiliates

FINEPOINT PARTNERS LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
FINEPOINT CAPITAL PARTNERS I, L.P. Hedge Fund $1,811.9M $10.0M 88
FINEPOINT CAPITAL PARTNERS II, L.P. Hedge Fund $2,206.9M $10.0M 55

Control Persons

Name Type Entity Title Since Ownership
WAGNER, HERBERT, SCHWIND Individual MANAGING PARTNER (CHIEF EXECUTIVE OFFICER) 03/2013 50-75%
FPCAP LLC Domestic Entity GENERAL PARTNER 03/2013 < 5%
WAGNER, HERBERT, SCHWIND Individual FPCAP LLC MANAGING MEMBER 03/2013 > 75%
VEZINA, STACY, LYNN Individual CHIEF COMPLIANCE OFFICER AND GENERAL COUNSEL 02/2014 < 5%
WAGNER, CHARLOTTE, CRAMER Individual LIMITED PARTNER 03/2013 25-50%
LEFKOWITZ, STEVEN, LAURENCE Individual PARTNER AND CHIEF OPERATING OFFICER 06/2013 < 5%
ALEXANDRA CRAMER WAGNER 2014 TRUST Domestic Entity BRATTLE HOLDINGS LLC MEMBER 07/2014 25-50%
BRATTLE HOLDINGS LLC Domestic Entity LIMITED PARTNER 07/2014 10-25%
CLAIRE CRAMER WAGNER 2014 TRUST Domestic Entity BRATTLE HOLDINGS LLC MEMBER 07/2014 25-50%
LUKE CRAMER WAGNER 2014 TRUST Domestic Entity BRATTLE HOLDINGS LLC MEMBER 07/2014 25-50%
CASPER, MICHAEL, JAY Individual BRATTLE HOLDINGS LLC TRUSTEE 07/2014
CRAMER MELNIK, MELISSA, ROSE Individual BRATTLE HOLDINGS LLC TRUSTEE 07/2014
CAFLISCH, TIMOTHY, STEPHEN Individual PARTNER 02/2020 < 5%
STOLLER, ERIN, BURKE Individual CHIEF FINANCIAL OFFICER 02/2023 < 5%

No. Employees, Historic

2010020202021202220232024202517 on 3/27/202017 on 3/30/202118 on 3/29/202218 on 3/8/202320 on 3/21/2024

RAUM, Historic

5B3B02020202120222023202420253355431957 on 3/27/20203820455517 on 3/30/20214057737656 on 3/29/20223543697997 on 3/8/20234018863744 on 3/21/2024

No. Clients, Historic

10502020202120222023202420252 on 3/27/20202 on 3/30/20212 on 3/29/20222 on 3/8/20232 on 3/21/2024

Holdings

From latest 13F, filed August 13th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
ACADIA PHARMACEUTICALS INC COM 15M 905K
ARGENX SE SPONSORED ADR 23M 54K
ARVINAS INC COM 15M 574K
ASCENDIS PHARMA A/S SPONSORED ADR 26M 189K
CALIDI BIOTHERAPEUTICS INC COM NEW 25K 125K
CALIDI BIOTHERAPEUTICS INC *W EXP 03/14/202 28K 655K
CHURCHILL CAPITAL CORP VII *W EXP 02/29/202 192K 548K
COMPASS DIGITAL ACQUISITION CORP *W EXP 09/29/202 28K 460K
CONCORD ACQUISITION CORP II *W EXP 99/99/999 45K 408K
CYTOKINETICS INC COM NEW 14M 256K
EYEPOINT PHARMACEUTICALS INC COM NEW 6M 707K
GALAPAGOS NV SPON ADR 13M 543K
LAKESHORE BIOPHARMA CO LTD *W EXP 03/15/202 33K 490K
LIBERTY BROADBAND CORP COM SER C 109M 2M
MARBLEGATE ACQUISITION CORP *W EXP 08/31/202 27K 735K
MONEYHERO LIMITED *W EXP 09/13/202 72K 895K
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD 17M 389K
PROTHENA CORP PLC SHS 9M 433K
RELAY THERAPEUTICS INC COM 10M 2M
REVOLUTION MEDICINES INC COM 28M 729K
SAREPTA THERAPEUTICS INC COM 21M 133K
SOLID BIOSCIENCES INC COM NEW 5M 961K
SPRINGWORKS THERAPEUTICS INC COM 24M 638K
SWIFTMERGE ACQUISITION CORP *W EXP 12/13/202 39K 490K
TRAVERE THERAPEUTICS INC COM 15M 2M